You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Obtenez les dernières mises à jour ou faites une autoévaluation.

Effectuez un dépistage du virus de l'hépatite B chez tous les patients cancéreux débutant un traitement systémique. Apprenez-en davantage sur le dépistage et la gestion du virus de l'hépatite B.

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

Que contient le nouveau formulaire de médicaments

Vous trouverez ici toutes les monographies de médicaments et de régimes nouvelles et récemment mises à jour, ainsi que les fiches de renseignements sur les patients et les documents de sécurité et de conseils.

Regimen
Published Date: 26 Apr 2024
Cancer Type:
Gastrointestinal, 
Hepatobiliary / Liver / Bile Duct
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated administration section with pharmacy and nursing workload.

Updated
Apr 2024
Regimen
Published Date: 26 Apr 2024
Cancer Type:
Gastrointestinal, 
Hepatobiliary / Liver / Bile Duct
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated the administrative section with nursing and pharmacy workload

Updated
Apr 2024
Regimen
Published Date: 26 Apr 2024
Cancer Type:
Hematologic, 
Lymphoma - Non-Hodgkin's High Grade, 
Lymphoma - Non-Hodgkin's Intermediate Grade
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated to reflect the availability of a universal compassionate program for drug costs

Updated
Apr 2024
Regimen
Published Date: 25 Apr 2024
Cancer Type:
Hematologic, 
Leukemia - Acute Lymphoblastic (ALL)
Intent: Curative
Revision Summary:

Regimen Monograph: Changed imatinib to ODB general benefit

Updated
Apr 2024
Regimen
Published Date: 25 Apr 2024
Cancer Type:
Hematologic, 
Leukemia - Acute Lymphoblastic (ALL)
Intent: Curative, Palliative
Revision Summary:

Regimen Monograph: Changed imatinib to ODB General Benefit

Updated
Apr 2024
Regimen
Published Date: 25 Apr 2024
Cancer Type:
Sarcoma, 
Soft Tissue
Intent: Palliative
Revision Summary:

Regimen Monograph: Changed imatinib to ODB general benefit

Updated
Apr 2024
Regimen
Published Date: 25 Apr 2024
Cancer Type:
Hematologic, 
Leukemia - Chronic Myeloid (CML)
Intent: Palliative
Revision Summary:

Regimen Monograph: Modified Supplementary Public Funding section

Updated
Apr 2024
Regimen
Published Date: 25 Apr 2024
Cancer Type:
Gastrointestinal, 
Gastrointestinal Stromal Tumours, 
Sarcoma, 
GIST
Intent: Palliative
Revision Summary:

Regimen Monograph: Changed imatinib to ODB general benefit

Updated
Apr 2024
Regimen
Published Date: 25 Apr 2024
Cancer Type:
Gastrointestinal, 
Gastrointestinal Stromal Tumours, 
Sarcoma, 
GIST
Intent: Adjuvant
Revision Summary:

Regimen Monograph: Changed imatinib to ODB general benefit

Updated
Apr 2024
Drug

Published Date: 25 Apr 2024

Revision Summary:
Drug Monograph: Modified Supplementary Public Funding section
Updated
Apr 2024
Regimen
Published Date: 23 Apr 2024
Cancer Type:
Gastrointestinal, 
Gastric / Stomach
Intent: Palliative
Revision Summary:

Regimen Monograph: new ST-QBP regimen

New
Apr 2024
Regimen
Published Date: 23 Apr 2024
Cancer Type:
Gastrointestinal, 
Gastric / Stomach
Intent: Palliative
Revision Summary:

Regimen Monograph: new ST-QBP regimen

New
Apr 2024

Pages